Related Insights
ACA Subsidy Cuts and Medical Device Demand: What the Regulatory Ripple Means for Healthcare Supply Chains
ACA subsidy reductions are emerging as a factor affecting medical procedure growth, with implications for medical device demand and healthcare manufacturing. Procurement professionals should understand how healthcare policy changes can influence purchasing patterns across the pharmaceutical and medical technology sectors.
One Big Beautiful Bill Act: What US Chemical Companies Need to Know About the New Policy Landscape
US industrial policy continues to evolve alongside environmental regulation. This article explains how the One Big Beautiful Bill Act fits into the broader policy environment influencing chemical manufacturing, investment planning and regulatory compliance.
India Duty Waiver Expiry: Impact on Petrochemical Imports and Chemical Buyers
India duty waiver expiry is creating urgent decisions for chemical importers and manufacturers as the customs exemption deadline approaches. Buyers must assess possible cost increases across key petrochemical products and adjust Q3 sourcing strategies.
India Chemical Import Duty Reset 2026: What Buyers Need to Know After the Waiver Ends
India’s chemical procurement market enters a new cost environment after the customs duty exemption ended on July 1. Buyers must now recalculate landed costs as duties return across key petrochemical raw materials.
Force Majeure Wind-Down in H1 2026: Legal and Commercial Reset for Chemical Supply Contracts
Force majeure declarations triggered by the Hormuz crisis are now entering a structured wind-down phase across chemical supply chains. Procurement and legal teams must formalise documentation to avoid pricing disputes, liability gaps and contract ambiguity in H2 2026.
TSCA Week 1 Post-Expiry Assessment: Chemical Companies Face Longer EPA Review Timelines
With the TSCA fee authority ending on June 22, chemical firms must brace for extended EPA review periods under the OPPT framework. This post outlines what companies can expect in the next 12 months and highlights key compliance steps before the 2026 TSCA reauthorization debate.
Don't miss out on our updates! Subscribe to our newsletter now
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.